mediaTUM
Universitätsbibliothek
Technische Universität München
Benutzer: Gast
Login
de
en
Erweiterte Suche
mediaTUM Gesamtbestand
Hochschulbibliographie
Elektronische Prüfungsarbeiten
Open Access Publikationen
Forschungsdaten
TUM.University Press
Sammlungen
Projekte
Einrichtungen
Forschungszentren
Hochschulpräsidium
Hochschulreferate
Partnerschaftliche Einrichtungen
Schools
TUM School of Computation, Information and Technology
(45871)
TUM School of Engineering and Design
TUM School of Life Sciences
Prüfungsarbeiten
(3192)
Departments
Güter
Zentren
(289)
Kleintierforschungszentrum Weihenstephan (Prof. Klingenspor)
Bayerisches Zentrum für Biomolekulare Massenspektrometrie (BayBioMS)
(289)
Autor
Jahr
(283)
TUM Plant Technology Center (PTC)
Animal Research Center (ARC)
(32)
TUM Forschungslaboratorium Holz (Benz komm. / Van de Kuilen)
(118)
Ehemalige Einrichtungen
(2853)
TUM School of Management
TUM School of Medicine and Health
TUM School of Natural Sciences
(14811)
TUM School of Social Sciences and Technology
(9138)
TUM Campus Straubing für Biotechnologie und Nachhaltigkeit
Serviceeinrichtungen
TUM Institute for LifeLong Learning
Zentrale Verwaltung
mediaTUM Gesamtbestand
Einrichtungen
Schools
TUM School of Life Sciences
Zentren
Bayerisches Zentrum für Biomolekulare Massenspektrometrie (BayBioMS)
Zurück
Zurück zum Anfang der Trefferliste
Dauerhafter Link zum angezeigten Objekt
Titel:
Chemoproteomics-Aided Medicinal Chemistry for the Discovery of EPHA2 Inhibitors
Dokumenttyp:
Zeitschriftenaufsatz
Autor(en):
Heinzlmeir, Stephanie; Lohse, Jonas; Treiber, Tobias; Kudlinzki, Denis; Linhard, Verena; Gande, Santosh Lakshmi; Sreeramulu, Sridhar; Saxena, Krishna; Liu, Xiaofeng; Wilhelm, Mathias; Schwalbe, Harald; Kuster, Bernhard; Médard, Guillaume
Abstract:
The receptor tyrosine kinase EPHA2 has gained attention as a therapeutic drug target for cancer and infectious diseases. However, EPHA2 research and EPHA2-based therapies have been hampered by the lack of selective small-molecule inhibitors. Herein we report the synthesis and evaluation of dedicated EPHA2 inhibitors based on the clinical BCR-ABL/SRC inhibitor dasatinib as a lead structure. We designed hybrid structures of dasatinib and the previously known EPHA2 binders CHEMBL249097, PD-173955, and a known EPHB4 inhibitor in order to exploit both the ATP pocket entrance as well as the ribose pocket as binding epitopes in the kinase EPHA2. Medicinal chemistry and inhibitor design were guided by a chemical proteomics approach, allowing early selectivity profiling of the newly synthesized inhibitor candidates. Concomitant protein crystallography of 17 inhibitor co-crystals delivered detailed insight into the atomic interactions that underlie the structure-affinity relationship. Finally, the anti-proliferative effect of the inhibitor candidates was confirmed in the glioblastoma cell line SF-268. In this work, we thus discovered a novel EPHA2 inhibitor candidate that features an improved selectivity profile while maintaining potency against EPHA2 and anticancer activity in SF-268 cells. © 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
Stichworte:
EPH receptor; chemical proteomics; drug discovery; inhibitors; selectivity profiling
Zeitschriftentitel:
ChemMedChem
Jahr:
2017
Band / Volume:
12
Heft / Issue:
12
Seitenangaben Beitrag:
999-1011
Volltext / DOI:
doi:10.1002/cmdc.201700217
Verlag / Institution:
Wiley-Blackwell
E-ISSN:
1860-7179
Publikationsdatum:
12.06.2017
BibTeX
Vorkommen:
mediaTUM Gesamtbestand
Einrichtungen
Hochschulpräsidium
TUM Senior Excellence Faculty
mediaTUM Gesamtbestand
Hochschulbibliographie
2017
Fakultäten
Wissenschaftszentrum Weihenstephan
Bayerisches Zentrum für Biomolekulare Massenspektrometrie (BayBioMS)
mediaTUM Gesamtbestand
Einrichtungen
Schools
TUM School of Life Sciences
Zentren
Bayerisches Zentrum für Biomolekulare Massenspektrometrie (BayBioMS)
Jahr
2017